Mariana Mogezel-Salem

Mariana Mogezel-Salem

Auto-generated profile, based on publicly available information

Mariana Mogezel-Salem

School of Neurobiology, Biochemistry and Biophysics, Tel Aviv University 4 Faculty of Life Sciences Tel Aviv

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2025 in Journal of Experimental Medicine
Verified
Journal Article
Open access
SBShir Bergson
Shir Bergson
OSOfer Sarig
Ofer Sarig
MGMoshe Giladi
Moshe Giladi
JMJanan Mohamad
Janan Mohamad
MMMariana Mogezel-Salem
Mariana Mogezel-Salem
ESEli Sprecher
Eli Sprecher
Epidermolysis bullosa simplex (EBS) refers to a heterogeneous group of inherited skin disorders characterized by blister formation within the basal cell layer. The disease is characterized by marked variations in phenotype severity, suggesting co-inheritance of genetic modifiers. We identified three deleterious variants in HMCN1 that co-segregated with a more severe phenotype in a group of 20 individuals with EBS caused by mutations in KRT14, encoding keratin 14 (K14). HMCN1 codes for hemicentin-1. Protein modeling, molecular dynamics simulations, and functional experiments showed that all three HMCN1 variants disrupt protein stability. Hemicentin-1 was found to be expressed in human skin above the BMZ. Using yeast-2-hybrid, co-immunoprecipitation, and proximity ligation assays, we found that hemicentin-1 binds K14. Three-dimensional skin equivalents grown from hemicentin-1–deficient cells were found to spontaneously develop subepidermal blisters, and HMCN1 downregulation was found to reduce keratin intermediate filament formation. In conclusion, hemicentin-1 binds K14 and contributes to BMZ stability, which explains the fact that deleterious HMCN1 variants co-segregate with a more severe phenotype in KRT14-associated EBS.